Neutralizing monoclonal antibodies raised against intact foot-and-mouth disease virus reacted with intact particles and with isolated VP1 from different strains from the same subtype. Prior treatment of the virus with either trypsin or with arginine-specific protease abolished recognition of both the virus and of VP 1, suggesting the presence of a neutralization epitope in the central region of VP1 cleaved by these two enzymes. A synthetic peptide analogue of part of this region showed poor reactivity, however, with neutralizing antibody.
INTRODUCTION
The foot-and-mouth disease virus (FMDV) virion consists of one molecule of single-stranded RNA and 60 copies of each of four polypeptides designated VP 1, VP2, VP3 and VP4 (Cooper et al., 1978) . Treatment of the intact 146S virion with trypsin results in the cleavage of only VP1 with a loss of infectivity and of immunogenicity, implying that the major antigenic sites of the virus are located on VP1 and that this protein is located on the surface of the virion (Wild et al., 1969) . Using classical protein cleavage techniques, Adam et al. (1978) and B achrach et al. (1979) were able to fractionate VP1 and to indicate which regions of the molecule were implicated in the antigenic site. Following molecular cloning of FMDV cDNA in Escherichia coli by , Kurz et al. (1981) determined the coding sequence for VP1 and the inferred sequence of 213 amino acids that constitute the immunogenic protein. On the basis of these sequence data and the definitive identification of the immunogenic fragments produced by enzymic or cyanogen bromide cleavage of VP1, Strohmaier et al. (1982) were able to assign the antigenic sites of VP1 to positions 141 to 160 and 201 to 213 of the polypeptide chain. This assignment was later refined to residues 144 to 159 (Pfaff et al., 1982) . Meanwhile, Bittle et aL (1982) predicted the probable antigenic sites of VP1 on theoretical grounds by comparing the sequences of different viral serotypes to identify variable regions of high hydrophilicity that might be responsible for antigenic variation. One of the regions identified corresponds with the 141 to 160 region selected by Strohmaiers's group.
It has now been shown by Bittle et al. (1982) and by Pfaffet al. (1982) that synthetic peptides corresponding to these regions of VP1 can, when coupled to an appropriate protein carrier, elicit a neutralizing antibody response sufficient to protect immunized animals against subsequent virulent virus challenge.
In the present study, we have prepared neutralizing monoclonal antibodies against FMDV type Ol Aulendorf and examined the binding of ond°of them (D7) to the cleavage products of VP1 to determine whether this antibody, prepared against whole virus, also recognizes the sequence identified in the studies outlined above.
METHODS
Virus preparation. FMDV types O1 Aulendorf, A5 Allier and Ct Vosges were grown in BHK-21 suspension cultures in 15001 fermenters and purified by adsorption on polyoxyethylene prior to inactivation using bromoethyleneimine (Duchesne et al., 1982) .
Preparation of VP1. VP1 was prepared using essentially the procedure of Bachrach et al. (1975) . Purified virus was degraded by heating at 100 °C for 5 min in 0.05 M-Tris-HCI pH 8.6 containing 6M-urea and I% 2-mercaptoethanol. VP1 was isolated by chromatography on QAE-Sephadex A-25 using a batchwise procedure. The purity of the isolated VP 1 was established by SDS-PAGE using the discontinuous buffer system of Laemmli (1970) as previously described (Duchesne et al., 1982) . Gels were fixed, stained with Coomassie Brilliant Blue and destained.
Transfer ofpolypeptides to nitrocellulose filters. Virus polypeptides were transferred from SDS polyacrylamide slab gels using methods similar to those described by Bowen et al. (1980) and by Petit et al. (1982) . After electrophoresis, the SDS gel was shaken in transfer buffer (50 mM-NaCI, 2 mM-sodium EDTA, 4 M-urea, 0.1 mMdithiothreitol, 10 mM-Tris-HCl pH 7.0) for 2 h at 20 °C. The partially renatured proteins were transferred for 20 h at 20 °C from the gel to two nitrocellulose filters using the protein blot system described by Bowen et al. (1980) . The filters were then incubated for 30 min at 20 °C in 10 mM-phosphate buffer pH 7.4, 150 mM-NaCI, 3~ NP40. The sheets were next washed in saline buffer (10 mM-Tris-HC1 pH 7-4, 150 mM-NaC1, 0-1 ~ Tween 20), and finally incubated for 2 h at 37 °C in 10 mM-phosphate buffer pH 7-4, 150 mM-NaC1 containing 2~ bovine serum albumin to saturate the remaining protein-binding sites on the nitrocellulose. The sheets were washed free of unbound protein with saline buffer containing Tween 20. Protein transfer was verified by staining a strip of the nitrocellulose sheets with amido black (Towbin et al., 1979) and staining of the SDS gels by Coomassie Brilliant Blue.
Immunological detection ofpolypeptides on nitrocellulose. Strips cut from nitrocellulose sheets were incubated overnight at 20 °C with polyclonal antiserum (prepared as described by Guerche et al., 1972) or hybridoma culture fluid in 10 raM-phosphate buffer pH 7.4, 150 mM-NaCl, 2~ bovine serum albumin, 10~o calf serum and 0.1~ Tween 20. The strips were washed in saline buffer to remove excess antibody, then incubated at 37 °C for 2 h with peroxidase-labelled rabbit anti-mouse IgG used at 1:2000 dilution in saline buffer. The colour reaction was developed with 4-chloro-1-naphthol and hydrogen peroxide as described by Hawkes et al. (1982) . The reaction was stopped after l0 to 20 min by washing with distilled water. The strips were dried between filter papers and stored in the dark.
Enzymic cleavage ofviralpolypeptides. Proteolytic treatments were performed on sucrose gradient-purified virus. The virus suspension was dialysed against phosphate-buffered saline pH 8.0 and the virus concentration adjusted to about 2 mg/ml.
Mouse submaxillary gland protease (MSGP, Boehringer-Mannheim) was dissolved to a concentration of 100 units/ml (Strohmaier et al., 1982) and added to the virus suspension to give an enzyme to substrate ratio of 1:40. The mixture was incubated for 90 min at 37 °C and the reaction was then stopped by adding SDS and 2-mercaptoethanol to final concentrations of 1 ~ and 2~o respectively, and heating at 100 °C for 1 min.
Trypsin (TPCK-treated, Sigma) was added to the virus suspension at 50 ~tg/ml and the mikture was incubated at 37 °C for 1 h. The reaction was stopped by separating out the virus particles on a sucrose gradient.
For treatment with Staphylococcus aureus V8 protease (Miles Laboratories), puri£ed virus (2 mg/ml) was disrupted by heating at 100 °C for 1 min in 1 ~ SDS, 2~ 2-mercaptoethanol, 0.01 M-Tris-HC1 pH 7.4, 10~ (v/v) glycerol. V8 protease in 0.01 M-Tris-HCI pH 7.4, 1 mM-EDTA was added to give an enzyme to substrate ratio of 1:80 or 1:20. Digestion was for 1 h at 37 °C and was stopped by heating at 100 °C for 1 rain (Cleveland et al., 1977) .
Synthetic peptide. Peptide VPI-A, a hexadecapeptide corresponding to amino acids 144 to 159 of FMDV serotype Oj K VP1 (Pfaff et al., 1982) , was a gift from Dr H. Schaller.
Production ofhybridomas. Adult female BALB/c mice were first immunized by subcutaneous injections of 75 I.tg 146S particles from FMDV type O1 Aulendorf in Freund's complete adjuvant. Three additional injections with adjuvant were given on days 14, 28 and 42 and a final intraperitoneal injection was given without adjuvant 3 days before cell fusion.
Spleen cells from immunized mice were hybridized with SP2/O-Ag-14 myeloma cells (Flow Laboratories) using a modification of the general procedure of KShler & Milstein (1975) . About 108 spleen cells were mixed with 3 x 107 washed, exponential phase SP2/O-Ag-14 cells and the mixture was centrifuged from 10 ml of serum-free Dulbecco's modified Eagle's medium (DMEM) at 400 g for 8 min.
One ml of warm (40 °C) pH 8.4, polyethylene glycol [PEG 1500, 50~ (w/v) in DMEM] was then added to the cell pellet. After a 1 min fusion, 1 ml of DMEM was added dropwise over 2 min, then 18 ml of DMEM + 20~o foetal calf serum (FCS) was added dropwise over a further 9 min. The fusion mixture was then diluted to 30 ml with DMEM + 20~ FCS and dispensed into two 25 cm z flasks and incubated overnight (37 °C, 8~ COz).
The mixture was then diluted with HAT medium containing 8 × 105 spleen feeder cells per ml from nonimmunized mice to give approximately 2 x 105 hybridoma cells/ml. This culture was distributed into eight 96-well microplates and incubated in 20~ FCS HAT medium at 37 °C in 8~ CO:.
After 10 days, viable hybrids were detected in all wells and all supernatants were screened by ELISA. Fifteen colonies producing antibody to FMDV 146S particles were selected and cloned, initially using a "mini cloning' procedure adapted from Nowinski et al. (1979) , then by limiting dilution. Eleven clones that continued to produce antibody were finally obtained.
ELISA. Indirect ELISA was used essentially as described by Abu Alzein & Crowther (1978) using Linbro microtitre plates containing 0-5/.tg of purified 146S virion or 0-2 ~g of VP 1 fixed in each well. Absorbance values were determined using a LOV-I plate scanner (Bio Merieux) and titration results were calculated using the regression method of Franz et al. (1982) . Virus neutralization test. Neutralizing activity was determined in a microtitre system using IBR $2 pig kidney cells (Guerche et al., 1972) . Hybridoma supernatants were tested in fourfold dilution steps against about 100 TCIDso of virus. Endpoints, determined according to Reed & Muench (1938) , are expressed as the negative log of the hybridoma supernatant dilution resulting in virus neutralization. Hybridoma supernatants were considered positive if their titre exceeded 0-6.
RESULTS

Serotype specificity of antibody-secreting clones
The 11 producer clones selected for further analysis were assayed by ELISA for their reactivity against intact virus particles of different serotypes. Reaction was obtained with the immunizing virus as well as with other strains of the O serotype. Type C virus gave a limited reaction (5 to 10 ~) with some clones and no reaction was detectable with type A virus ( Table 1) .
Virus neutralization by monoclonal antibodies
Culture supernatants from the 11 producer clones were tested for their capacity to neutralize different virus serotypes. Six clones were identified which neutralized the immunizing strain of virus and other strains of the O serotype. The other five clones, although positive by ELISA, were unable to neutralize type O virus. As in the ELISA, a limited cross-reactivity was seen with the C serotype strains and no neutralization with the A serotype (Table I ). These inter-serotype differences were confirmed using other virus subtypes; O1 Campos, C 3 Indaial and Az2 Venceslau gave the same responses as O1 Aulendorf, C1 Vosges and A5 Allier respectively.
Preliminary localization of the site(s) recognized by the monoclonal antibodies
Culture supernatants from 11 clones were assayed by ELISA for their capacity to recognize intact O virus before and after trypsin treatment. Additionally, the capacity to recognize isolated VP1 from type O virus was verified for one of the clones. These results indicate that for the neutralizing clones (A6, D8, E7, A8, D7 and G 10) trypsin treatment of the virus results in loss of recognition, implying that the site(s) recognized by these clones are in trypsin-sensitive regions of VP1 (Table 2) .
Identification of monoclonal antibody recognition sites by immunoblotting
The neutralizing clones were tested against the isolated capsid proteins of several type O virus strains by immunoblotting and compared with a polyclonal antibody from hyperimmune 
• + + +, Positive reaction; -, negative reaction. guinea-pigs (Table 3) . Results with O1 Aulendorf are given in Table 3 ; identical results were obtained with O1 Lausanne, Oi Campos and O Yala 1979. The reaction was still positive using antibody diluted 100-fold. These neutralizing clones were also tested against isolated capsid proteins from A-and C-type virus. No reaction was detectable even with undiluted antibody. These results reinforce the conclusion that the neutralizing monoclonal antibodies recognize sites on VP1 from type O virus. The neutralizing polyclonal antibody used in the same experiment showed positive reaction with all three viral protein bands whereas pooled nonneutralizing monoclonal antibodies, which had previously been shown to react with the intact virus, gave no reaction with the isolated viral proteins.
Region VP1 recognized by neutralizing monoclonal antibody D7
Protease treatment of intact virus was used to produce VP 1 cut at defined sites and the digests were analysed by SDS-PAGE (Fig. 1) . As expected, cleavage with trypsin resulted in the production of two fragments of VP 1 as described by Wild et al. (1969) (Fig. 1 b) . Two fragments were also observed ( Fig. 1 e,f) after treatment with MSGP as has been described by Strohmaier et aL (1982 Positive reaction with the antibody is observed only with intact VP1 and with several V8 fragments.
In addition, denatured viral proteins were treated with the glutamic acid-specific staphylococcal V8 protease, resulting in the production of multiple smaller fragments of VP1 (Fig. 1 c, d) .
The binding of antibody D7 to these fragments was then analysed by immunoblotting (Fig. 2) . In the case of trypsin treatment (Fig. 2b) reactivity with the antibody was abolished, in agreement with the ELISA data already quoted. The VP1 fragments produced by MSGP treatment also gave no reaction with D7 (Fig. 2e, f) . These results indicate that the regions of VP1 recognized by the antibody D7 are susceptible to cleavage by both trypsin and by MSGP.
V8 protease treament of denatured VP1 results in the production of at least four fragments that give a positive reaction with antibody D7 (Fig. 2c, d ). The smallest of these fragments has a molecular weight of around 6.5 x 103.
Reaction with peptide VP1-A
In inhibition experiments, antibody D7 was preincubated with either intact virus or with peptide VP 1-A corresponding to amino acids 144 to 153 of VP 1 from F MDV type O1K, prior to estimation of unreacted antibody in the standard ELISA test with virus-coated microplates. In this system antibody binding to the plate was totally abolished by preincubation with virus at 2 ~tg/ml, whereas 50 ~tg/ml of peptide VP1-A was needed to inhibit binding by 50~. In other experiments (not shown) the effect of peptide VP 1-A on antibody-virus complex formation was investigated using density gradient centrifugation to reveal the formation of complexes, and also direct interaction of VP1-A with antibody D7 was investigated using an HPLC system. In no case were we able to demonstrate recognition of the peptide by antibody D7.
DISCUSSION
The data presented here indicate that the neutralizing monoclonal antibody D7 reacts with an antigenic determinant of FMDV type O. This site is recognized in the intact virus in neutralization tests and by ELISA, as well as in isolated denatured VP1 by ELISA and by immunoblotting. Additionally, the site is still apparently recognizable in the relatively low molecular weight 6500 fragment produced by protease V8 digestion. These observations suggest that D7 responds to a 'sequential' antigenic site on VP1.
Antibody D7 shows no cross-reactivity with type A virus although there is a limited crossreaction with type C virus which is most marked (around 5 ~ cross-reaction) in the virus neutralization tests. This finding is difficult to explain since, by definition, such cross-reactivity between serotypes is not seen with classical antisera. Conceivably this represents a low-affinity interaction which is not seen against the background of multiple high-affinity interactions seen with a potent polyclonal antibody. Interestingly, interaction with type C virus (but not with type A) was observed by Pfaff et al. (1982) working with sera against small synthetic peptides from type O1K VP1 although Bittle et al. (1982) , working with similar peptides, observed no such cross-reaction.
Controlled proteolysis of intact virions by trypsin or by MSGP results in specific cleavage of VP1 (Strohmaier et aL, 1982) . Since none of the peptides generated by this hydrolysis is recognized by antibody D7 it appears that the sequential determinant recognized by D7 is in the protease-sensitive region of VP1. Both enzymes produce two major fragments of VP1, those produced by MSGP representing together the whole of the sequence of VP ( Fig. 1 and 2 ). While trypsin cleaves VP1 at several points, MSGP is thought to cleave VP1 from FMDV type O1 Kaufbeuren at a single site between Arg 145 and Gly 146 (Strohmaier et al., 1982) .
The published sequences of several O1 strains show an MSGP cleavage site in the same position Cheung et al., 1983) . The sequence of O1 Aulendorf is as yet unknown to us but the immunoblotting results after proteolytic cleavage strongly suggest that O1 Aulendorf retains this cleavage site. This is consistent with a tentative localization of the D7 site in a zone that includes the MSGP-sensitive bond between amino acids 145 and 146. The failure of the hexadecapeptide 144 to 159 to react convincingly with antibody D7 was therefore somewhat unexpected, since this peptide is capable of provoking the production of neutralizing antibodies (Pfaff et al., 1982) and also contains the MSGP cleavage site at Arg 145.
Several possible explanations may be advanced for this lack of recognition. Firstly, despite the retained reactivity with denatured VP 1 and its V8 protease fragments, it is possible that the D7 site has certain conformational properties which are not reproduced in the synthetic peptide. Secondly, it is possible that the assumption made regarding the sequence of the Aulendorf strain is incorrect and that the MSGP cleavage does not occur at residues 144 and 145 in this virus strain. Equally, other amino acid changes may exist in our virus which result in significant changes from the antigenic site(s) of peptide 145 to 159.
Although the sequences around the supposed susceptible bond are very similar in several O1 strains (Cheung et al., 1983) it has been possible to clone serologically distinct variants with VP1 differing at residues 148 and 153 from a single parental stock of type A virus (Rowlands et at., 1983) . Such variation cannot be ruled out with other virus preparations.
Another explanation might be that antibody D7 has requirements for structural features that include other residues on the N-terminal side of the susceptible bond, whereas peptide VP1-A represents predominantly the sequence in the C-terminal direction. In this connection the recent studies of Robertson et al. (1983) are interesting since they have shown that a VPl-derived tyrosine-containing peptide, 136 to 144, occupies a superficial position in intact virus serotype A12. This peptide is therefore considered to represent at least part of the antigenic region of VP1. Our data may indicate that antibody D7 recognizes a sequence that straddles the MSGP cleavage site and thus contains residues from both the 136 to 144 and the 144 to 159 peptides. Further cleavage and analysis of the 6500 tool. wt. V8 fragment recognized by antibody D7 is planned to order to resolve this question.
At least two other neutralization epitopes of FMDV have been identified using monoclonal antibodies. Both show characteristics different to that described is this report, since one was shown to be sensitive to conformational changes in the virus (Ouldridge et al., 1984) while the other is retained after cleavage by trypsin (Ouldridge et al., 1984; Meloen et al., 1983) . Neither of these monoclonal antibodies reacts with isolated VP1 and they presumably recognize 'conformational' antigenic sites.
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